Literature DB >> 8373680

Cardiac arrhythmias as a manifestation of acquired heart disease in association with paediatric respiratory syncitial virus infection.

D S Armstrong1, S Menahem.   

Abstract

Respiratory syncitial virus (RSV) is a common cause of upper and lower respiratory tract infection in infants. An association between RSV bronchiolitis and cardiac arrhythmias has been described but is rare. A further case of an infant with supraventricular tachycardia in association with culture-positive respiratory syncitial virus bronchiolitis is reported. This case prompted a review of the two other cases of arrhythmia associated with RSV infection seen at this institution and a review of all other published cases.

Entities:  

Mesh:

Year:  1993        PMID: 8373680     DOI: 10.1111/j.1440-1754.1993.tb00519.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  9 in total

1.  Changes in cardiac output and stroke volume as measured by non-invasive CO monitoring in infants with RSV bronchiolitis.

Authors:  Julie Caplow; Sarah C McBride; Garry M Steil; Jackson Wong
Journal:  J Clin Monit Comput       Date:  2012-04-24       Impact factor: 2.502

2.  Prolonged sinoatrial block in an infant with respiratory syncytial viral bronchiolitis.

Authors:  Wajed Haddad; Melissa Agoudemous; Sangita Basnet
Journal:  Pediatr Cardiol       Date:  2012-03-03       Impact factor: 1.655

3.  Supraventricular tachycardia after respiratory syncytial virus infection in a newborn.

Authors:  Seda Aydoğan; Nurdan Dinlen Fettah; Ali Ulaş Tuğcu; Ece Koyuncu; Tamer Yoldaş; Ayşegül Zenciroğlu
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-06-14

4.  Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection.

Authors:  Susanna Esposito; Patrizia Salice; Samantha Bosis; Silvia Ghiglia; Elena Tremolati; Claudia Tagliabue; Laura Gualtieri; Paolo Barbier; Carlotta Galeone; Paola Marchisio; Nicola Principi
Journal:  BMC Infect Dis       Date:  2010-10-24       Impact factor: 3.090

Review 5.  Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 6.  New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.

Authors:  Nicolás M S Gálvez; Jorge A Soto; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

7.  Case report of severe myocarditis in an immunocompromised child with Respiratory Syncytial Virus infection.

Authors:  Hiroki Miura; Fumihiko Hattori; Hidetoshi Uchida; Tadayoshi Hata; Kazuko Kudo; Masatoki Sato; Tetsushi Yoshikawa
Journal:  BMC Pediatr       Date:  2018-02-12       Impact factor: 2.125

Review 8.  Antibody development for preventing the human respiratory syncytial virus pathology.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Susan M Bueno; Alexis M Kalergis
Journal:  Mol Med       Date:  2020-04-17       Impact factor: 6.354

9.  Respiratory syncytial virus-associated mortality in a healthy 3-year-old child: a case report.

Authors:  A Gavotto; A Ousselin; O Pidoux; P Cathala; V Costes-Martineau; B Rivière; J L Pasquié; P Amedro; C Rambaud; G Cambonie
Journal:  BMC Pediatr       Date:  2019-11-27       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.